Skip to main content
Log in

Alternative Variants of Pax4 Human Transcription Factor: Comparative Transcriptional Activity

  • MOLECULAR CELL BIOLOGY
  • Published:
Molecular Biology Aims and scope Submit manuscript

Abstract

MODY is a group of genetically and clinically heterogeneous forms of diabetes characterized by autosomal dominant inheritance and is subdivided in 13 subtypes dependent on the gene involved. The subtype MODY9 is a very rare form caused by mutations in the gene encoding the PAX4 transcription factor which is engaged in differentiation of pancreatic beta-cells. PAX4 contains two DNA-binding domains—Paired and Homeo. Expression of the human PAX4 gene is tissue-specific. The alternatively spliced mRNA variants encode for protein isoforms which differ within their N- and C-terminal regions. In this study, the transcriptional activities of the human PAX4 variants, both known and new ones, were determined. The full-length PAX4 containing intact DNA-binding domains was found to have maximal activity in transient expression system of the firefly luciferase reporter gene under control of the insulin promoter in HEK293 cells. The transcriptional activity is significantly reduced in the variants lacking eight N-terminal amino acid residues and/or variants whose Homeo domain is truncated from the C-terminus. Similar data were obtained with the glucagon promoter reporter system. The aberrant PAX4 variants were shown to retain stability and nuclear localization.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

Similar content being viewed by others

REFERENCES

  1. Petersen H.V., Jørgensen M.C., Andersen F.G., Jensen J., F-Nielsen T., Jørgensen R., Madsen O.D., Serup P. 2000. Pax4 represses pancreatic glucagon gene expression. Mol. Cell Biol. Res. Commun.3, 249–254.

    Article  CAS  Google Scholar 

  2. Estreicher A., Gauthier B.R., Mamin A., Edlund H., Philippe J. 2002. The pancreatic beta-cell-specific transcription factor Pax4 inhibits glucagon gene expression through Pax 6. Diabetologia.45, 97–107.

    Article  Google Scholar 

  3. Wang Q., Elghazi L., Martin S., Martins I., Srinivasan R.S., Geng X., Sleeman M., Houghton J.,Sosa-Pineda B. 2008. Ghrelin is a novel target of Pax4 in endocrine progenitors of the pancreas and duodenum. Dev. Dyn.237, 51–61.

    Article  CAS  Google Scholar 

  4. Campbell S.C., Cragg H., Elrick L.J., Macfarlane W.M., Shennan K.I.J., Docherty K. 1999. Inhibitory effect of Pax4 on the human insulin and islet amyloid polypeptide (IAPP) promoters. FEBS Lett.463, 53–57.

    Article  CAS  Google Scholar 

  5. Vaxillaire M., Froguel P. 2008. Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial form of type 2 diabetes. Endocr. Rev.29, 254–264.

    Article  CAS  Google Scholar 

  6. Biason-Lauber A., Boehm B., Lang-Muritano M., Gauthier B.R., Brun T., Wollheim C.B., Schoenle E.J. 2005. Association of childhood type 1 diabetes mellitus with a variant of PAX4: Possible link to beta cell regenerative capacity. Diabetologia. 48, 900–905.

    Article  CAS  Google Scholar 

  7. Smith S.B., Ee H.C., Conners J.R., German M.S. 1999. Paired-homeodomain transcriptional repressor in early pancreatic development. Mol. Cell. Biol.8, 8272–8280.

    Article  Google Scholar 

  8. Plengvidhya N., Kooptiwut S., Songtawee N., Doi A., Furuta H., Nishi M., Banchuin N. 2017. PAX4 mutations in Thais with maturity onset diabetes of the young. J. Clin. Endocrinol. Metab.92, 2821–2826.

    Article  Google Scholar 

  9. Martin-Montalvo A., Lorenzo P.I., Lopez-Noriega L., Gauthier B.R. 2016. Targeting pancreatic expressed PAX genes for the treatment of diabetes mellitus and pancreatic neuroendocrine tumors. Expert. Opin. Ther. Targets. 21, 77–89.

    Article  Google Scholar 

  10. Sujjitjoon J., Kooptiwut S., Chongjaroen N., Tangjittipokin W., Plengvidhya N., Yenchitsomanus P.T. 2016. Aberrant mRNA splicing of paired box 4 (PAX4) IVS7–1G>A mutation causing maturity-onset diabetes of the young, type 9. Acta Diabetol. 53, 205–216.

    Article  CAS  Google Scholar 

  11. Fujitani Y., Kajimoto Y., Yasuda T., Matsuoka T.A., Kaneto H., Umayahara Y., Fujita N., Watada H., Miyazaki J.I., Yamasaki Y., Hori M. 1999. Identification of a portable repression domain and an E1A-responsive activation domain in Pax4: A possible role of Pax4 as a transcriptional repressor in the pancreas. Mol. Cell. Bio-l.19, 8281–8291.

    Article  CAS  Google Scholar 

  12. Tokuyama Y., Yagui K., Sakurai K., Hashimoto N., Saito Y., Kanatsuka A. 1998. Molecular cloning of rat Pax4: Identification of four isoforms in rat insulinoma cells. Biochem. Biophys. Res. Commun. 248, 153–156.

    Article  CAS  Google Scholar 

  13. Miyamoto T., Kakizawa T., Ichikawa K., Nishio S., Kajikawa S., Hashizume K. 2001. Expression of dominant negative form of PAX4 in human insulinoma. Biochem. Biophys. Res. Commun. 282, 34–40.

    Article  CAS  Google Scholar 

  14. Lorenzo P.I., Ju F., Cobo-Vuilleumier N., Garc M., Gauthier B.R. 2017. The diabetes-linked transcription factor PAX4 : From gene to functional consequences. Genes.8, 101. https://doi.org/10.3390/genes8030101

    Article  CAS  PubMed Central  Google Scholar 

  15. https://www.proteinatlas.org/

  16. Brink C., Chowdhury K., Gruss P. 2001. Pax4 regulatory elements mediate beta cell specific expression in the pancreas. Mech. Dev.100, 37–43.

    Article  CAS  Google Scholar 

  17. Brun T., Duhamel D.L., He K.H.H., Wollheim C.B., Gauthier B.R. 2007. The transcription factor PAX4 acts as a survival gene in INS-1E insulinoma cells. Oncogene.26, 4261–4271.

    Article  CAS  Google Scholar 

  18. Lu J., Li G., Lan M. S., Zhang S., Fan W., Wang H., Lu D. 2007. Pax4 paired domain mediates direct protein transduction into mammalian cells. Endocrinology.148, 5558–5565.

    Article  CAS  Google Scholar 

  19. Hui K., He H., Lorenzo P.I., Brun T., Moreno C.M.J., Aeberhard D., Gauthier B.R. 2011. In vivo conditional Pax4 overexpression in mature islet β-cells prevents stress-induced hyperglycemia in mice. Diabetes. 60, 1705–1715.

    Article  Google Scholar 

  20. Lee G., Jang H., Kim Y.Y., Choe S.S., Kong J., Hwang I., Park J., Im S.-S., Kim J.B. 2019. SREBP1c-PAX4 axis mediates pancreatic β-cell compensatory responses upon metabolic stress. Diabetes.68, 81–94.

    Article  CAS  Google Scholar 

  21. Lorenzo P.I., Cobo-Vuilleumier N., Gauthier B.R. 2018. Therapeutic potential of pancreatic PAX4-regulated pathways in treating diabetes mellitus. Curr. Opin. Pharmacol. 43, 1–10.

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported by the Russian Foundation for Basic Research (project nos. 17-29-06028 and 18-04-01271).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. M. Rubtsov.

Ethics declarations

Conflict of interest. The authors declare no conflict of interest.

Statement of the welfare of animals. No studies on animals or humans were carried out.

Additional information

Translated by A. Boutanaev

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Melnikova, A.I., Krasnova, T.S., Zubkova, N.A. et al. Alternative Variants of Pax4 Human Transcription Factor: Comparative Transcriptional Activity. Mol Biol 54, 749–756 (2020). https://doi.org/10.1134/S0026893320050076

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0026893320050076

Keywords

Navigation